The aminosteroid U73122 promotes oligodendrocytes generation and myelin formation.

[1]  Yue Yin,et al.  Hepatic G Protein-Coupled Receptor 180 Deficiency Ameliorates High Fat Diet-Induced Lipid Accumulation via the Gi-PKA-SREBP Pathway , 2023, Nutrients.

[2]  Min Wang,et al.  The orphan G protein‐coupled receptor GPR149 is a negative regulator of myelination and remyelination , 2022, Glia.

[3]  F. Kirchhoff,et al.  L-Type Ca2+ Channels of NG2 Glia Determine Proliferation and NMDA Receptor-Dependent Plasticity , 2021, Frontiers in Cell and Developmental Biology.

[4]  Drew J. Adams,et al.  Screening Reveals Sterol Derivatives with Pro-Differentiation, Pro-Survival, or Potent Cytotoxic Effects on Oligodendrocyte Progenitor Cells. , 2021, ACS chemical biology.

[5]  H. Sakagami,et al.  Phospholipase D and phosphatidylinositol-4-phosphate 5-kinase 1 are involved in the regulation of oligodendrocyte morphological differentiation. , 2021, Experimental cell research.

[6]  M. Cayre,et al.  Myelin Repair: From Animal Models to Humans , 2021, Frontiers in Cellular Neuroscience.

[7]  M. Qiu,et al.  Genetic Evidence that Dorsal Spinal Oligodendrocyte Progenitor Cells are Capable of Myelinating Ventral Axons Effectively in Mice , 2020, Neuroscience Bulletin.

[8]  V. Gorgoulis,et al.  Cellular senescence and failure of myelin repair in multiple sclerosis , 2020, Mechanisms of Ageing and Development.

[9]  Bing Zhang,et al.  Suppressing PLCγ1 enhances osteogenic and chondrogenic potential of BMSCs. , 2020, Biochemical and biophysical research communications.

[10]  R. Jabs,et al.  Properties of human astrocytes and NG2 glia , 2020, Glia.

[11]  Chad A. Cowan,et al.  GPR146 Deficiency Protects against Hypercholesterolemia and Atherosclerosis , 2019, Cell.

[12]  R. Resende,et al.  Decoding cell signalling and regulation of oligodendrocyte differentiation. , 2019, Seminars in cell & developmental biology.

[13]  Haifeng Gu,et al.  Inhibition of MAPK/ERK pathway promotes oligodendrocytes generation and recovery of demyelinating diseases , 2019, Glia.

[14]  E. Bettelli,et al.  Experimental Autoimmune Encephalomyelitis (EAE) as Animal Models of Multiple Sclerosis (MS). , 2018, Cold Spring Harbor perspectives in medicine.

[15]  W. K. Wilson,et al.  Accumulation of 8,9-unsaturated sterols drives oligodendrocyte formation and remyelination , 2018, Nature.

[16]  Linchuan Liao,et al.  G-Protein-Coupled Receptor Gpr17 Regulates Oligodendrocyte Differentiation in Response to Lysolecithin-Induced Demyelination , 2018, Scientific Reports.

[17]  Qianting Yuan,et al.  Vitamin C promotes oligodendrocytes generation and remyelination , 2018, Glia.

[18]  D. Rowitch,et al.  Origin and dynamics of oligodendrocytes in the developing brain: Implications for perinatal white matter injury , 2017, Glia.

[19]  D. Duong,et al.  Mice lacking Gpr37 exhibit decreased expression of the myelin-associated glycoprotein MAG and increased susceptibility to demyelination , 2017, Neuroscience.

[20]  K. Monk,et al.  G Protein-Coupled Receptors in Myelinating Glia. , 2016, Trends in pharmacological sciences.

[21]  Chao Zhao,et al.  Tamoxifen accelerates the repair of demyelinated lesions in the central nervous system , 2016, Scientific Reports.

[22]  Changsheng Du,et al.  Kappa opioid receptor activation alleviates experimental autoimmune encephalomyelitis and promotes oligodendrocyte-mediated remyelination , 2016, Nature Communications.

[23]  E. Peles,et al.  G protein-coupled receptor 37 is a negative regulator of oligodendrocyte differentiation and myelination , 2016, Nature Communications.

[24]  W. Richardson,et al.  Oligodendrocyte Development and Plasticity. , 2016, Cold Spring Harbor perspectives in biology.

[25]  H. Takebayashi,et al.  Oligodendrocyte generation during mouse development , 2015, Glia.

[26]  P. Paez,et al.  Voltage-gated Ca++ entry promotes oligodendrocyte progenitor cell maturation and myelination in vitro , 2015, Experimental Neurology.

[27]  P. Hylemon,et al.  Bile acids and sphingosine-1-phosphate receptor 2 in hepatic lipid metabolism , 2015, Acta pharmaceutica Sinica. B.

[28]  G. Corfas,et al.  The adhesion G protein-coupled receptor GPR56 is a cell-autonomous regulator of oligodendrocyte development , 2015, Nature Communications.

[29]  D. Gutmann,et al.  The adhesion GPCR Gpr56 regulates oligodendrocyte development via interactions with Gα12/13 and RhoA , 2014, Nature Communications.

[30]  Qing-shui Yin,et al.  PDGF regulates chondrocyte proliferation through activation of the GIT1- and PLCγ1-mediated ERK1/2 signaling pathway. , 2014, Molecular medicine reports.

[31]  Stephen L Hauser,et al.  Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis , 2014, Nature Medicine.

[32]  Ying-Hui Fu,et al.  Very large G protein-coupled receptor 1 regulates myelin-associated glycoprotein via Gαs/Gαq-mediated protein kinases A/C , 2013, Proceedings of the National Academy of Sciences.

[33]  F. Gage,et al.  A regenerative approach to the treatment of multiple sclerosis , 2013, Nature.

[34]  T. Blanck,et al.  Differential regulation of proliferation and neuronal differentiation in adult rat spinal cord neural stem/progenitors by ERK1/2, Akt, and PLCγ , 2013, Front. Mol. Neurosci..

[35]  Michelle M. Giddens,et al.  GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin , 2013, Proceedings of the National Academy of Sciences.

[36]  C. Lucchinetti,et al.  Pathology of demyelinating diseases. , 2012, Annual review of pathology.

[37]  D. Rowitch,et al.  Myelin regeneration: a recapitulation of development? , 2011, Annual review of neuroscience.

[38]  Nitin J. Karandikar,et al.  The oligodendrocyte-specific G-protein coupled receptor GPR17 is a cell-intrinsic timer of myelination , 2009, Nature Neuroscience.

[39]  D. Rowitch,et al.  Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. , 2009, Genes & development.

[40]  C. Wegner,et al.  Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. , 2008, Brain : a journal of neurology.

[41]  Jie Peng,et al.  Isolation and culture of rat and mouse oligodendrocyte precursor cells , 2007, Nature Protocols.

[42]  C. Dreyfus,et al.  Mitogen‐activated protein kinase pathway mediates effects of brain‐derived neurotrophic factor on differentiation of basal forebrain oligodendrocytes , 2006, Journal of neuroscience research.

[43]  R. Skoff,et al.  Comparison of in vivo and in vitro subcellular localization of estrogen receptors α and β in oligodendrocytes , 2004 .

[44]  W. Ho,et al.  Inhibition of acetylcholine‐activated K+ currents by U73122 is mediated by the inhibition of PIP2‐channel interaction , 2001, British journal of pharmacology.

[45]  Su-Chun Zhang.  Defining glial cells during CNS development , 2001, Nature Reviews Neuroscience.

[46]  D. Picard,et al.  Two compounds commonly used for phospholipase C inhibition activate the nuclear estrogen receptors. , 1999, Biochemical and biophysical research communications.

[47]  J. Mironneau,et al.  Effects of Phospholipase C Inhibitors on Ca2+Channel Stimulation and Ca2+Release from Intracellular Stores Evoked by α1A- and α2A-Adrenoceptors in Rat Portal Vein Myocytes , 1996 .

[48]  D. Raible,et al.  Induction of oligodendrocyte differentiation by activators of adenylate cyclase , 1990, Journal of neuroscience research.

[49]  Klaus-Armin Nave,et al.  Oligodendrocytes: Myelination and Axonal Support. , 2015, Cold Spring Harbor perspectives in biology.

[50]  S. Ryu,et al.  Phospholipase C-γ1 involved in brain disorders. , 2013, Advances in biological regulation.

[51]  K. Grandien,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors � and � , 2022 .